MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
Conformis Operating Cycle 2011-2026 | CFMS
Annual Operating Cycle Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 216 | 181 | 183 | 161 | 139 | 130 | 147 | 180 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 216 | 130 | 167 |
Quarterly Operating Cycle Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 214 | 292 | - | 240 | 209 | 200 | - | 212 | 152 | 210 | 46.5 | 184 | 176 | 176 | 50.9 | 172 | 162 | 145 | 54.7 | 136 | 150 | 140 | 58 | 141 | 134 | 130 | 61.8 | 156 | 149 | 145 | 71.1 | 192 | 163 | 168 | 58.5 | 165 | 86.7 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 292 | 46.5 | 149 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
160 | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | USA |
 |
Bruker Corporation
BRKR
|
274 | $ 39.37 | 0.24 % | $ 5.87 K | USA |
 |
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
156 | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 8.02 | 2.56 % | $ 576 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.17 | 4.51 % | $ 155 M |  France |
 |
AdaptHealth Corp.
AHCO
|
64 | $ 9.72 | 3.4 % | $ 1.31 B | USA |
 |
FONAR Corporation
FONR
|
251 | $ 18.55 | 0.27 % | $ 122 M | USA |
 |
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
270 | $ 43.46 | 0.12 % | $ 1.35 B | USA |
 |
Electromed
ELMD
|
228 | $ 23.79 | -0.56 % | $ 201 M | USA |
 |
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
279 | $ 29.86 | 0.1 % | $ 1.38 B | USA |
 |
Apyx Medical Corporation
APYX
|
299 | $ 3.28 | 3.48 % | $ 114 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | USA |
 |
InMode Ltd.
INMD
|
307 | $ 13.51 | -0.66 % | $ 873 M | Israel |
 |
IRIDEX Corporation
IRIX
|
170 | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
IRadimed Corporation
IRMD
|
308 | $ 106.1 | 1.74 % | $ 1.34 B | USA |
 |
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Accuray Incorporated
ARAY
|
233 | $ 0.52 | -0.89 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
130 | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | Israel |
 |
LivaNova PLC
LIVN
|
181 | $ 68.02 | -0.6 % | $ 3.71 B |  Britain |
 |
Cytosorbents Corporation
CTSO
|
175 | $ 0.79 | -1.52 % | $ 43 M | USA |
 |
Pulmonx Corporation
LUNG
|
337 | $ 1.5 | -2.29 % | $ 58.7 M | USA |
 |
Align Technology
ALGN
|
171 | $ 182.98 | 0.19 % | $ 13.7 B | USA |
 |
Medtronic PLC
MDT
|
237 | $ 96.27 | -0.48 % | $ 124 B | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
268 | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
866 | $ 3.92 | 6.52 % | $ 830 M | USA |
 |
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
181 | $ 113.6 | -0.01 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
425 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
359 | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 72.51 | -1.81 % | $ 107 B | USA |